SPECIFICITY AND REVERSIBILITY OF CHEMOTACTIC DEACTIVATION OF HUMAN-MONOCYTES

被引:17
|
作者
FALK, W
LEONARD, EJ
机构
关键词
D O I
10.1128/IAI.32.2.464-468.1981
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:464 / 468
页数:5
相关论文
共 50 条
  • [1] ADHESION OF HUMAN-MONOCYTES INDUCED BY CHEMOTACTIC FACTORS
    DOHERTY, DE
    HASLETT, C
    TONNESEN, MG
    HENSON, PM
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1286 - 1286
  • [2] GENERATION OF LEUKOTRIENES BY HUMAN-MONOCYTES IN RESPONSE TO A CHEMOTACTIC PEPTIDE
    WILLIAMS, JD
    LEE, TH
    AUSTEN, KF
    CLINICAL SCIENCE, 1986, 70 : P55 - P55
  • [3] THE EFFECT OF COLCHICINE AND VINBLASTINE ON THE CHEMOTACTIC RESPONSE OF HUMAN-MONOCYTES
    ZAKHIREH, B
    MALECH, HL
    JOURNAL OF IMMUNOLOGY, 1980, 125 (05): : 2143 - 2153
  • [4] CHEMOTACTIC AND STIMULATING EFFECT OF TUFTSIN AND ITS ANALOGS ON HUMAN-MONOCYTES
    KAVAI, M
    LUKACS, K
    SZEGEDI, G
    SZEKERKE, M
    ERCHEGYI, J
    IMMUNOLOGY LETTERS, 1981, 2 (04) : 219 - 224
  • [5] OXIDIZED LOW-DENSITY-LIPOPROTEIN IS CHEMOTACTIC FOR HUMAN-MONOCYTES
    QUINN, MT
    PARTHASARATHY, S
    STEINBERG, D
    CIRCULATION, 1986, 74 (04) : 378 - 378
  • [6] NOVEL NEUTROPHIL CHEMOTACTIC FACTOR DERIVED FROM HUMAN-MONOCYTES
    KOWNATZKI, E
    KAPP, A
    UHRICH, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1985, 84 (05) : 444 - 445
  • [7] PARTIAL CHARACTERIZATION OF FIBRONECTIN FRAGMENTS WHICH ARE CHEMOTACTIC FOR HUMAN-MONOCYTES
    CLARK, RAF
    NORRIS, DA
    HOWELL, SE
    FEDERATION PROCEEDINGS, 1983, 42 (03) : 386 - 386
  • [8] LEISHMANIA INTERACTION WITH HUMAN-MONOCYTES AND NEUTROPHILS - MODULATION OF THE CHEMOTACTIC RESPONSE
    SORENSEN, AL
    KHARAZMI, A
    NIELSEN, H
    APMIS, 1989, 97 (08) : 754 - 760
  • [9] OXIDIZED LOW-DENSITY-LIPOPROTEIN IS CHEMOTACTIC FOR HUMAN-MONOCYTES
    QUINN, MT
    PARTHASARATHY, S
    STEINBERG, D
    ARTERIOSCLEROSIS, 1986, 6 (05): : A563 - A563
  • [10] A SYNTHETIC AMINO-TERMINAL FIBRONECTIN FRAGMENT IS CHEMOTACTIC FOR HUMAN-MONOCYTES
    LOHR, KM
    SEYER, JM
    CLINICAL RESEARCH, 1989, 37 (02): : A509 - A509